Biopredic International
Created in 1993
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
251 2,016Activities
Technologies
Entity types
Location
La Bretèche, 35760 Saint-Grégoire, France
Saint-Grégoire
France
Employees
Scale: 11-50
Estimated: 25
Engaged corporates
3
2 1Added in Motherbase
5 years, 1 month ago
deeptech Value proposition
Biopredic International is committed to support Life Science Research by developing and distributing biological tools. We assist both academia and industries in drug development, drug discovery, cosmetic and chemical fields.
Biopredic International delivers assays, tissues, cells and reagents including:
> High quality hepatocytes (human and animal, fresh or cryopreserved) and other liver-derived products (microsomes, S9 fractions and cytosols)
> Skin products (fresh or frozen), including human skin discs and skin sheets (full thickness, dermatomed, stratum corneum), skin cells (keratinocytes, fibroblasts), subcellular fractions...
> Blood products, including whole blood, sera, plasma, PBMCs, lymphocytes, monocytes, dendritic cells, CD34...
> And other products such as biofluids (bile, gastric & intestinal fluids), non-standard human and animal tissues
Applications include:
- toxicology
- genotoxicity
- metabolism
- passage
- bioanalysis
- and tranporter analysis.
Biopredic International is also the exclusive worldwide licensor of HepaRG®, the human hepatic stem cell line patented by the French National Instituteof Health and Medical Research.
Google+: https://plus.google.com/+BiopredicInternationalSaintGrégoire/posts
Twitter: https://twitter.com/Biopredic_Intl
To apply for a position at Biopredic International please send your CV and cover letter to recrutement[at]biopredic.com
Hepatocytes, Human hepatic stem cell line, HepaRG, Primary cells, Human and animal tissues, Blood products, Subscellular fractions, ADMETox, Genotoxicity, Passage, Transporters, and Biological reagents and kitsOriginal language
Biopredic International is committed to support Life Science Research by developing and distributing biological tools. We assist both academia and industries in drug development, drug discovery, cosmetic and chemical fields.
Biopredic International delivers assays, tissues, cells and reagents including:
> High quality hepatocytes (human and animal, fresh or cryopreserved) and other liver-derived products (microsomes, S9 fractions and cytosols)
> Skin products (fresh or frozen), including human skin discs and skin sheets (full thickness, dermatomed, stratum corneum), skin cells (keratinocytes, fibroblasts), subcellular fractions...
> Blood products, including whole blood, sera, plasma, PBMCs, lymphocytes, monocytes, dendritic cells, CD34...
> And other products such as biofluids (bile, gastric & intestinal fluids), non-standard human and animal tissues
Applications include:
- toxicology
- genotoxicity
- metabolism
- passage
- bioanalysis
- and tranporter analysis.
Biopredic International is also the exclusive worldwide licensor of HepaRG®, the human hepatic stem cell line patented by the French National Instituteof Health and Medical Research.
Google+: https://plus.google.com/+BiopredicInternationalSaintGrégoire/posts
Twitter: https://twitter.com/Biopredic_Intl
To apply for a position at Biopredic International please send your CV and cover letter to recrutement[at]biopredic.com
Wepredic
https://wepredic.com/en/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 SATT Ouest Valorisation Research, Startup accelerator & VC, Research Services | SATT Ouest Valorisation Research, Startup accelerator & VC, Research Services | Other 17 Nov 2022 | | |
 Images & Réseaux Public business cluster, French Cluster, IT Services and IT Consulting | Images & Réseaux Public business cluster, French Cluster, IT Services and IT Consulting | Not capitalistic Not partnership Event 18 Jun 2019 | | |
 Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Not capitalistic Partnership Not event 9 Jan 2018 | | |